ALEXANDRIA, Virginia, May 7 -- ONCOCEUTICS, INC., Philadelphia, Pennsylvania has been assigned a patent (No. US 11976068 B2, initially filed June 24, 2021) developed by six inventors Joshua E. Allen, New Haven, Connecticut; Martin Stogniew, Lakewood Ranch, Florida; Richard S. Pottorf, Indianapolis, Indiana; Bhaskara Rao Nallaganchu, Hillsborough, New Jersey; Gary Olson, Mountainside, New Jersey; and Yanjun Sun, Kendall Park, New Jersey, for "7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimid . . .